Neobe Therapeutics Raises $6.8M Seed to Attack Tumor Barriers

UK biotech Neobe Therapeutics raised $6.8M in seed funding led by ARC Ventures to advance engineered bacteria that break down tumor barriers, targeting an IND filing in 2028.